Introduction
Since grafts exchanged between two siblings with an identical IL-A genotype are subject to a degree of rejection little greater than that occurring in transplants between identical twins (Stickel et al., 1967) , there can be little doubt that HL-A or a closely adjacent locus carries the most important genetic determinants for histocompatibility in man. That HL-A is indeed the major locus is confirmed by the demonstration that preimmunization of a recipient with cells carrying foreign HL-A antigens will cause accelerated rejection of a subsequent graft from a donor with these antigens (Dausset et al., 1965 ; van Rood et al., 1965; Kissmeyer-Nielsen et al., 1966; Terasaki et al., 1968; Patel and Terasaki, 1969; Stewart et al., 1969) , that purified preparations of soluble HL-A antigens can stimulate lymphocytes in culture (Viza et al., 1968) , and that donor-specific HL-A antibodies appear in patients at the time of rejection of renal allografts (Manzler, 1968; Morris et al., 1969) . When transplants are exchanged between unrelated donor-recipient pairs, however, it is not always possible to show a correlation between HL-A matching and early acceptance or rejection of renal allogmfts (Patel et al., 1968) .
Tissue matching has been used in Sydney for recipient selection in a city-wide collaborative programme of cadavericdonor renal transplantation since 1967 (Sheil et al., 1969) . One-sixth of the grafts in this series underwent early acute rejection, but these rejections could not (Sheil et al., 1968; Tracy et al., 1969) . The diagnosis of rejection was confirmed by demonstration of the characteristic lesions in a biopsy or nephrectomy specimen of the graft (Porter et al., 1963; Kincaid-Smith, 1967) .
HL-A typing of donor and recipient was performed by a microdroplet lymphocyte cytotoxicity test developed from those described by Walford et al. (1964) and Terasaki et al. (1967) . Throughout this analysis the concept of an HL-A locus with at least two discrete subloci, designated "LA" and "4" (Kissmeyer-Nielsen et al., 1968) , has been used. Reliable sera detecting five allelic antigens of the "LA" sublocus, HLAl, 2, 3, 9, and 11 (S Ly2) and five of the "4" sublocus, 7, 8, 12 (S Lyl) , and S Ly5 were used. S Ly5 has yet to be identified with any previously described antigen. One additional allele at the "4" sublocus, designated "4c" (R* of Kissmeyer-Nielsen), could be recognized in subjects whose cells were (Table  II) . Separate examination of the data for each of the antigens failed to show any significant association between early acute rejection and incompatibility of any one antigen when considered alone (Table III (Table IV) it could be seen that ensuring that there was no inconpatibility at the "LA" sublocus alone did not reduce significantly the rate of early failure. The numbers were too smal to determine whether or not compatibility at the "4" sublocus alone or at both the "LA" and the "4" sublocl would avoid acute rejection. Walford (1969) , most of the undetected antigens will be incompatible. If the antigens of the two HL-A subloci were randomly associated the frequency with which a recipient will be found to match a completely typed donor would be equal to R (2pipj.2qiqj) where i, j=l, 2......n n=number of alleles at each sublocus pi or pj represents the gene frequency of an allele of the "LA" sublocus qi or qj represents the gene frequency of an allele of the "4" sublocus R represents the proportion of ABO compatible recipients in the population
The most common phenotype (HL-Al, HL-A2, HL-A7, HL-A12), if found in a blood group 0 donor, would be compatible for about 6 per 1,000 of the recipient population, and the least common phenotype (HL-A9, HL-All, HL-A5, S Ly5), if group 0, for about 4 per 100,000. In fact, the antigens are not randomly associated, for HL-Al and 8, HL-A2 and 12, HL-A3 and 7, and HL-All and "4c" tend to occur together ( Sharp et al., 1970) . This increases the frequencies of the common phenotypes, so that, Bamw MiDncAL JOURVL 489 for example, HL-A1, HL-A8, HL-A2, HL-A12 would occur in about 2% of potential recipients instead of the calculated 4 per 1,000. Nevertheless, the common phenotypes, for which a recipient pool of rather less than 1,000 would suffice, comprise no more than 10-20% of the population. For the remainder the patient pool would need to exceed 1,000 to ensure the availability of two compatible recipients.
Discussion
The ultimate aim of tissue typing for cadaveric-donor transplantation must be to achieve excellent acceptance of the graft by ensuring complete HL-A compatibility. This requires identification and matching of all four donor antigenic determinants of the "LA" and "4" subloci and of both determinants of any further subloci which may be discovered. For identification, a panel composed of antisera with limited and known specificity and detecting each of the individual alleles, is necessary, and, for matching, an enlarged recipient pool numbering more than 1,000.
Throughout this study certain assumptions have been madein particular, that all HL-A antigens have a roughly equal capacity to induce graft rejection and that incompatibilty even for a single antigen should be avoided. Previously published evidence concerning the relative strengths of the known HL-A antigens has been summarized by Walford (1969) , whose conclusions support the validity of the first assumption. And in the present series, whereas no one of the recognized antigens, when considered individually, was clearly associated with early rejection, it can be inferred from the rejection of five grafts in which no identifiable antigen was incompatible that at least some of the unrecognized antigens have the capacity to induce acute rejection.
There are several possible explanations for our failure to show a correlation between the number of incompatibilities, either demonstrated or potential, and early acute rejection: (1) that early rejection is as much determined by the immunological reactivity of the recipient as by the antigenic disparity present; (2) that a single incompatibility is as important as several; (3) that there are additional HL-A subloci besides the two described; (4) that certain combinations of antigens act synergistically, or else, conversely, the presence of one antigen in the recipient may induce a degree of tolerance to a closely related antigen in the graft; and (5) that non-HL-A antigens play a rather greater part in early than in late rejec- (Patel et al, 1968) .
The second possibility seems to be ruled out by the knowledge that kidney grafts from HL-A identical siblings are accepted better than are parent-child grafts, in which only one-half of the antigenic determinants are matched (Singal et al., 1969) , and these in turn fare better than do grafts between unrelated pairs with, on the whole, fewer than half the antigens matched. In this series there were two grafts which were rejected despite matching of three of the four "LA" and "4" antigens. In the single instance in which the fourth mismatched antigen was identified it was HL-A5.
The possibility of there being third and fourth HL-A subloci has been raised by Walford et al. (1969) . If such should be the case, and the strength of their alleles proves to be comparable to those of the "LA" and "4" subloci, the results in this -series could be readily explained. Moreover, unless their antigenic determinants are more strongly associated with those of other subloci than has been demonstrated for "LA" and "4" alleles (Sharp et al., 1270), it will be virtually impossible to achieve identical matching of donor and recipient.
Knowledge concerning immunological interrelationships, as distinct from genetic associations, in the HL-A system is scanty, as are data concerning the role of non-HL-A antigens other than those of the ABO system. The observation that no combination of mismatched recognized antigens was associated with early acute xejection in the present series does not rule out a synergistic action between antigens, for the number of rejected grafts was small and a significant proportion of antigens were not identified.
We believe that incompatibility of the less easily recognized HL-A antigens, and presensitization without formation of detectable cytotoxic antibodies, will prove to be major factors determining the early acute rejection of allografts from unrelated donors.
